RxDoctor Payments Data

Matthew Mai, MD

Orthopaedic Surgery · Fort Walton Beach, FLNPI 1003902354

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (42.8%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Smith+Nephew accounts for 66.2% of it on its own, with 22 other manufacturers making up the rest. Reporting peaked in 2021 at $36,546 and has fallen 56.7% since, to $15,842 in 2025. Among orthopaedic surgery clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$135,136in general payments, 2019–2025

Across 343 payments — averaging $393.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$89K
  • Zimmer Biomet$39K
  • Corelink, LLC$2K
  • Medacta USA, Inc.$1K
  • Spinal Simplicity, LLC$685
  • Stryker$492
  • plus $1K from 17 others
$33,051in research payments, 2019–2025

Across 17 payments — averaging $1944.18 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Smith+Nephew$25K
  • Zimmer Biomet$8K

What the payments were for

  • Consulting fees$57,78543%
  • Speaking & faculty fees$49,39937%
  • Travel & lodging$16,32612%
  • Food & beverage$11,6269%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$135,136 in reported general payments places this provider in the 90th percentile of 1,263 orthopaedic surgery providers in Florida.

See all orthopaedic surgery providers in Florida →

Medicare billing

Part B allowed, 2024
$530,680
Medicare patients
617
Services billed
5,552

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban17$9,234
Celecoxib291$4,430
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen241$2,818
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen137$2,106
Ondansetron Hcl106$1,298
Cyclobenzaprine Hcl56$623
Tramadol Hcl99$454
Methylprednisolone34$219
Diclofenac Sodium15$156
Hydromorphone Hcl23$137
Mupirocin14$98
Omeprazole13$71
Meloxicam14$64
Amoxicillin27$30

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Fort Walton Beach

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →